IMA910
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMA910, covering 2013-05-16 to 2013-05-16. Get the full timeline:
Most recent: Clinical Trial Update: IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) [Phase 1, Phase 2]